INIS
patients
100%
rats
94%
levels
55%
drugs
46%
doses
39%
cancer
39%
control
37%
indonesia
36%
inflammation
36%
proteins
36%
comparative evaluations
33%
therapy
31%
mice
31%
curcumin
30%
liver
30%
plasma
28%
concentration
27%
kidneys
26%
humans
26%
reviews
25%
diseases
25%
oxidation
22%
administration
21%
breasts
21%
hospitals
20%
blood
20%
tissues
19%
risks
17%
toxicity
17%
messenger-rna
17%
safety
17%
glucose
17%
antioxidants
16%
genes
16%
dextran
16%
doxorubicin
15%
tuberculosis
15%
interventions
15%
sodium sulfates
14%
in vitro
14%
angiotensin
14%
stem cells
14%
streptozotocin
14%
receptors
14%
colon
13%
fibrosis
13%
apoptosis
12%
nanoparticles
12%
clinical trials
12%
evaluation
12%
children
12%
diet
12%
males
11%
adults
11%
populations
11%
values
11%
diabetes mellitus
11%
insulin
11%
in vivo
11%
weight
10%
aging
10%
ethanol
10%
iron
10%
damage
10%
fats
10%
animals
10%
data
10%
injection
10%
reduction
9%
applications
9%
biological markers
9%
interactions
9%
ulcers
9%
ovaries
8%
correlations
8%
injuries
8%
antibiotics
8%
modulation
8%
peptides
8%
fibrin
7%
inhibition
7%
mitochondria
7%
leukemia
7%
growth factors
7%
women
7%
sensitivity
7%
lipids
7%
viruses
7%
hyaluronic acid
6%
enzymes
6%
pediatrics
6%
hypertension
6%
wounds
6%
endoplasmic reticulum
6%
myeloid leukemia
6%
management
6%
mutations
6%
coronaries
6%
cost
6%
assessments
6%
Keyphrases
Indonesia
41%
Curcumin
35%
Indonesian
23%
Oxidative Stress
19%
Leaf Extract
15%
Sprague-Dawley Rats
14%
Phaleria Macrocarpa
14%
Doxorubicin
13%
Jakarta
13%
Dextran Sulfate Sodium
13%
Rat Model
13%
Cisplatin
12%
MRNA Expression
11%
Nanocurcumin
11%
Mangiferin
11%
Pada
11%
Mahkota Dewa
10%
α-mangostin
9%
Clinical Trials
9%
Apoptosis
9%
Randomized Controlled Trial
9%
Inflammation
9%
Ethanol Extract
8%
Diabetic Foot Ulcer
8%
Protective Effect
8%
Antioxidant System
8%
Endoplasmic Reticulum Stress (ER stress)
7%
Daunorubicin
7%
Hyaluronic Acid
7%
Drug Transporters
7%
Kidney
7%
Antioxidant
7%
Protein Expression
7%
Platelet-rich Fibrin
7%
Liver
7%
Placebo
7%
Primaquine
7%
Streptozotocin-induced Diabetic Rats
7%
COVID-19
7%
Moringa Oleifera
7%
Iron Overload
7%
Insulin Resistance
7%
Leukemia Patients
7%
Tumor Necrosis Factor-α
6%
Streptozotocin-induced
6%
Streptozotocin
6%
Tuberculosis Patients
6%
Cardiotoxicity
6%
Plasma Concentration
6%
Type 1 Diabetes Mellitus (T1DM)
6%
Type 2 Diabetes Mellitus (T2DM)
6%
Oxidative Stress Markers
6%
Risk Factors
6%
Beneficial Effects
6%
Metabolic Syndrome
6%
Negative Control
6%
Anti-inflammatory Effect
6%
Interleukin-6
6%
Confidence Interval
5%
Nephrotoxicity
5%
Diabetes
5%
Diabetic Nephropathy
5%
In Vitro Study
5%
MCF-7
5%
Caspase-3
5%
Breast Cancer Cells
5%
Angiotensin II (Ang II)
5%
Rifampicin
5%
High-fat Diet
5%
Hepatic Stellate Cells
5%
Randomized Placebo-controlled Trial
5%
Healthy Volunteers
5%
Prostate
5%
Triple-negative Breast Cancer Cells
5%
Cardioprotection
5%
Diabetic
5%
Tuberculosis Treatment
5%
Mouse Colon
5%
Meta-analysis
5%
Pulmonary Tuberculosis
5%
Treatment Group
5%
Pharmacology, Toxicology and Pharmaceutical Science
Curcumin
34%
Antioxidant
19%
Diabetes Mellitus
17%
Streptozotocin
16%
Inflammation
15%
Dextran Sulfate
15%
Breast Cancer
15%
Messenger RNA
15%
Doxorubicin
15%
Cisplatin
14%
Sprague Dawley Rat
14%
Randomized Controlled Trial
13%
Diseases
12%
Placebo
11%
Mangiferin
11%
Malignant Neoplasm
10%
Pharmacokinetics
10%
Cardiotoxicity
10%
Moringa oleifera
10%
Rat Model
10%
Clinical Trial
9%
Tumor Necrosis Factor
9%
Biological Marker
9%
Cross-Sectional Study
9%
Caspase 3
9%
Iron
8%
Daunorubicin
7%
Infection
7%
Malonaldehyde
7%
Nephrotoxicity
7%
Receptor
7%
Cyclorphan
7%
Primaquine
7%
Side Effect
7%
Adverse Event
7%
Platelet-Rich Fibrin
6%
Insulin Resistance
6%
Interleukin 6
6%
Iron Poisoning
6%
Normal Human
6%
Cytokine
6%
Adverse Drug Reaction
6%
Fibrosis
5%
Hyaluronic Acid
5%
Clopidogrel
5%
Mouse Model
5%
Congestive Heart Failure
5%
Antiinflammatory Activity
5%
Rifampicin
5%
Liver Fibrosis
5%
Non Insulin Dependent Diabetes Mellitus
5%
Neuroprotective Agent
5%
Creatinine
5%
Metabolic Syndrome X
5%
Diabetic Nephropathy
5%
Wound
5%
Angiotensin II
5%
Angiotensin
5%